Back to results
US 2021/0275579 A1Published application
Electrochemically activated salt solution
AssigneeAzad Pharma AG
InventorsMihran BARONIAN, Fabio CARLI, Elisabetta CHIELLINI, Ernest BAEHLER
Life of this patent
Estimating the term…
Abstract
The present application refers to an electrochemically activated salt solution (EGAS), its production, and its use for treating infections.
Claims15
Electrochemically activated salt solution (ECAS) comprising
- a content of total chlorine of between 1 and 500 mg/l, preferably 100-450 mg/l,
- a content of chloride of between 2 and 8 g/l, preferably 3-7 g/l,
- a redox potential of +150 to +1,350 mV, preferably +600 to +1,100 mV, more preferably +700 to +1,050 mV, more preferably +700 to +1,000 mV,
- an osmolality of 20-800 mOsm/kg, preferably 200-400 mOsm/kg, more preferably 250-350 mOsm/kg,
- a pH value of 6.0-7.8, preferably 7.1-7.4, and
- optionally at least one (salt of) boric acid and/or at least one (salt of) phosphoric acid.
3 more elements
Dependencies are inferred from the claim text.